Acublate Overview
- Founded
- 2010
- Status
- Out of Business
- Latest Deal Type
- Out of Business
Acublate General Information
Description
Provider of therapeutic services designed to offer novel ultrasound device for the treatment of cancer. The company's therapeutic services include development of devices that use phased array technology consisting of transducers, resulting in focused beams that can be steered in three-dimensional imaging, providing consumers with ultrasound surgery devices to treat and melt cancer tumors.
Contact Information
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Surgical Devices
Primary Office
- Angel Building
- 407 Saint John Street
- London EC1V 4AD
- England, United Kingdom
Acublate Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 05-Feb-2019 | 00000 | Completed | Out of Business | ||
| 1. Early Stage VC | 27-Jan-2012 | 00000 | 00000 | 00.000 | Completed | Startup |
Acublate Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 000 | 0000 | 0000 | 00 | 0000 | 00.000 |